Clinical Trial Update: Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) [EARLY_Phase 1]

View source ↗

Summary

An EARLY_PHASE1 clinical trial is evaluating Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for relapsed or refractory non-small cell lung cancer; the current statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zeushield Cytotoxic T Lymphocytes (Z-CTLs)

Snippet

Sponsor: Yu Fenglei | Conditions: Non-small Cell Lung Cancer | EARLY_Phase 1 | Status: UNKNOWN